Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of adding quetiapine fumarate sustained-release (SEROQUEL SR) to antidepressant therapy for major depressive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SEROQUEL SR (Quetiapine Fumarate Sustained Release) (quetiapine fumarate sustained-release)

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED